From August 17, 2023 to March 31, 2024, the company has repurchased 3,040,219 shares, representing 0.63% for CNY 203.98 million. With this, the company has completed the repurchase of 3,040,219 shares, representing 0.63% for CNY 203.98 million under the buyback announced on August 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
62.3 CNY | -1.46% | +1.30% | -6.92% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.92% | 4.19B | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-13.85% | 32.43B | |
+55.39% | 24.28B | |
-15.47% | 15.52B | |
-41.29% | 12.17B | |
-14.84% | 12.01B | |
-11.75% | 12B | |
+7.57% | 8.87B |
- Stock Market
- Equities
- 688363 Stock
- News Bloomage BioTechnology Corporation Limited
- Tranche Update on Bloomage BioTechnology Corporation Limited's Equity Buyback Plan announced on August 17, 2023.